featured
Epcoritamab Monotherapy for Relapsed or Refractory Follicular Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Haematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study
Lancet Haematol 2024 Jun 13;[EPub Ahead of Print], KM Linton, U Vitolo, W Jurczak, PJ Lugtenburg, E Gyan, A Sureda, JH Christensen, B Hess, H Tilly, R Cordoba, DJ Lewis, C Okada, M Hutchings, MR Clausen, JM Sancho, T Cochrane, S Leppä, MED Chamuleau, D Gernhardt, I Altıntaş, Y Liu, T Ahmadi, MH Dinh, D Hoehn, E Favaro, B Elliott, C Thieblemont, JM VoseFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.